| RDS is a nuclear technology solutions company specializing in the decontamination of radioactive surfaces. We provide engineering clean-up services based on our proprietary radionuclide ion-specific decontamination solutions.
RDS solves radiological decontamination problems through the use of our proprietary solutions. They remove radioactive contamination to acceptable levels within minutes. The solutions are water based and work by dislocating radioactive ions enabling them to be easily removed. This process provides improved decontamination, lowered dose, and major cost savings.
Our patent-pending solutions are effective on Radioactive Halogens such as iodine and fluorine; Transition Metals such as cesium and cobalt; and Actinides such as uranium, plutonium, and americium. Published data (available upon request) shows remarkable decontamination results (High Decontamination Factors (100 to 500) are common).
We operate in three market segments: Nuclear Power Industry Applications, Homeland Security Applications, and Commercial Applications.
Also, please see our related-technology sister company, Applied Biotherapeutics, LLC at www.AppBio.com.
Meet our Managing Directors:
Bruno J. Schmidt, B.S., M.B.A.
Mr. Schmidt is President and Managing Director of M & S Brachytherapy Services, LLC in Tampa, Florida. He has over 25 years experience in management, mechanical engineering, operations, consulting, manufacturing, process engineering, quality assurance, and production. His M.B.A. is in Operations Management and was awarded by Nova University in 1976. He also obtained a B.S. in Aircraft Maintenance Engineering Technology from Embry-Riddle Aeronautical University in Daytona Beach, Florida. He holds seven patents for medical devices and has six other inventions in various stages of the patent process.
John H. Kuperus, Ph.D., R.Ph., BCNP, N. Ph.
Dr. Kuperus is a radiochemist residing in Tampa, Florida. He directs all Research and Development efforts for the company. He has developed products and filed three patents in his field. Dr. Kuperus holds a Ph.D. in Applied Sciences and Nuclear Chemistry from Pacific Western University, an M.S. in Radiopharmacy from the University of Southern California School of Pharmacy, and a B.S. in Pharmacy from the University of the Pacific. He is a registered nuclear pharmacist in Florida and California.
Kuperus has 32 years experience as a radiochemist, pharmaceutical services manager, staff nuclear pharmacist, and radiologic pharmacy coordinator. He was the Principal Investigator for a Squibb Pharmaceuticals grant. Kuperus has taught extensively at universities and published 41 studies and articles and 10 abstracts in scholarly journals. He has been an invited lecturer in the U.S. and abroad.
Chuck Symmonds, BS,ME
Chuck has an extensive
background in manufacturing and quality management. He has
operated his own company, "Quality Services," a quality assurance consulting
company, for many years. Mr. Schmidt and Mr. Symmonds have worked together
successfully in the past at Needle and Infusion Technology, where Mr.
Symmonds was the Quality Assurance Consultant. He implemented the Quality
System for FDA Registration as a Manufacturer at both M&S Brachytherapy and Needle and
Infusion Technology, and will be coordinating all FDA and other governmental approvals for RDS. Mr. Symmonds has
a Bachelor of Science in Mechanical Engineering degree from Bradley
University in Peoria, IL.
Richard Ferrelli
Mr. Ferrelli is a private investor and entrepreneur. Since 1987, Mr. Ferrelli has been a founder of several successful companies and an investor in several venture capital and leveraged buyout transactions. Mr. Ferrelli received a B.A. in economics, Phi Beta Kappa and Summa Cum Laude, from Tufts University in Medford, Massachusetts.
|
